Overview

The Efficacy of Doxazosin for Cocaine Users

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

Doxazosin, an alpha 1-adrenergic receptor, may play an important role in cocaine addiction in humans. This study will evaluate the effectiveness of doxazosin in preventing drug relapse among cocaine dependent participants.

Phase:

Phase 1

Details

Lead Sponsor:

Baylor College of Medicine

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Adrenergic Antagonists
Cocaine
Doxazosin